|
RHI Magnestia India |
|
Magnified growth ahead |
|
Benefits
of group consolidation, wide product basket and capacity expansion plans bode
well for this MNC associate |
|
RHI
Magnestia India (formerly Orient Refractories) is a subsidiary of RHI
Magnestia of Austria. It is a leading manufacturer and supplier of high-grade
refractory products and solutions. The refractory products are mainly used in
high temperature manufacturing processes in iron and steel industry, metal
smelters, cement, glass industry and other industrial products. Demand for
refractory is primarily dependent on the consumption of steel, which accounts
for about 75% of the total value and the remaining is used for glass, cement,
non-ferrous, petrochemicals etc. RHI
Magnesita Group is the leading global supplier of high-grade refractory
products, systems and solutions. RHI Group has recently integrated all three
legal entities i.e. RHI India, a wholly owned subsidiary of RHI Group; RHI
Clasisl, a subsidiary where it held 53.7% stake and Orient Refractories
(ORL), a listed subsidiary where the group had 69.6% stake. Subsequent to
order dated May 5, 2021 the two subsidiary companies of RHI Magnesita in
India – RHI Clasil and RHI India merged into the public listed entity ORL.
Post amalgamation the shareholding of RHI Magnestia through Dutch US Holding
B.V., Dutch Brasil Holding B.V. and VRD Americas B.V. is 70.19% in ORL
(recently renamed as RHI Magestia India). The integration in to one legal
entity would now enable the RHI Magnestia Group to synergize, simplify and
consolidate its strengths in India and serve its ever-growing customers
better. The
company is expanding capacity and modernising all its plants and is bringing
in some high-end new products into the Indian markets. It is also pushing for
digitisation, automation, robotics etc. The company has embarked on expanding
the capacity of Odisha plant from 10000 tonnes per annum (tpa) to 18000 tpa
and the expanded capacity will be commissioned by end of 2021 and cater to
local demand. The company plans to spend Rs 350-400 crore in next four years
expanding its total capacity by around 35%, which will be funded through
internal accruals. The
company currently serves customers in more than 70 countries apart from
India. The parent, RHI Magnestia, through its strong network across the
world, is also the key driver for the company’s exports growth. The company
expects its current export contribution to total income to increase from
around 26% to 32-35% in 3-4 years. Export margins are better than domestic
margins. Net
sales for the fiscal ended March 2021 decreased 1% to Rs 1370.38 crore. Net
profit was up 1% to Rs 136.62 crore. Net sales for the quarter ended March
2021 increased 20% to Rs 407.34 crore. Net profit was up 33% to Rs 42.54
crore. Demand
for steel in India in 2021 is expected to be extremely strong as Government
has unveiled various infrastructure investments, production linked
incentives, support for rural people through infra development in rural
areas, complemented by restarting of construction activities across India
& recovery of auto industry. India per capita steel consumption at 60 kg
is just about one fifth of the world average and the National steel policy
2017 aims to increase the per capita steel consumption of the country to 160
Kg. by 2030-31 which require 300 tonne steel production capacity. During
second wave of Covid pandemic in March-Jun 2021 period, the diversion of
industrial oxygen for medical purpose has impacted the operations of steel
plants and the local lockdowns to control the pandemic has affected the steel
demand. However the Indian steel industry is expected to come back strongly
from Q2FY22. Similarly the other user industries are also expected to see
demand recovery from Q2FY22 strengthening refractory demand. Significant
rise in logistics cost makes domestic production of refractories more
competitive. This has resulted in demand shift to domestic players especially
in case of moderately valued products that were imported from China. Global
demand for steel and hence refractories is also bouncing back, in line with
progress on vaccination in different countries. The company expects to grow
in double digit in revenues in next two years. We
expect the company to register consolidated EPS of Rs 10 in FY22 and Rs 11.5
in FY23. The scrip was trading around Rs 326 at BSE on July 19, 2021. |
No comments:
Post a Comment